Ligand profile
ZINC2171256
Virtual-screening candidate from ZINC.
Bound to: KP13_00781 — Peptide deformylase
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC2171256- UniProt (similar protein)
Q9I7A8- Tanimoto
- 0.721
- Target protein
- KP13_00781
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 78.4
- −1 ≤ LogP ≤ 5 0.60
- MW ≤ 500 Da 266.3
- LogP ≤ 5 0.60
- H-bond donors ≤ 5 3
- H-bond acceptors ≤ 10 4
- Rotatable bonds ≤ 10 4
- TPSA ≤ 140 Ų 78.4
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
O=C(C[C@H]1Sc2ccccc2NC1=O)NCCOO=C(C[C@H]1Sc2ccccc2NC1=O)NCCO
InChI=1S/C12H14N2O3S/c15-6-5-13-11(16)7-10-12(17)14-8-3-1-2-4-9(8)18-10/h1-4,10,15H,5-7H2,(H,13,16)(H,14,17)/t10-/m1/s1InChI=1S/C12H14N2O3S/c15-6-5-13-11(16)7-10-12(17)14-8-3-1-2-4-9(8)18-10/h1-4,10,15H,5-7H2,(H,13,16)(H,14,17)/t10-/m1/s1
CEXOUVWHXWXOFU-SNVBAGLBSA-NCEXOUVWHXWXOFU-SNVBAGLBSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- GNR
- Homolog
- Q9I7A8
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC2171256 →
- ZINC ZINC20 ZINC2171256 →
- UniProt UniProt Q9I7A8 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC2171256”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_00781.
PDB 12
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 100
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).